TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 65 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $196,552 | +2040.2% | 62,200 | +347.7% | 0.00% | – |
Q2 2023 | $9,184 | -19.4% | 13,893 | -2.8% | 0.00% | – |
Q1 2023 | $11,400 | -98.0% | 14,293 | -94.4% | 0.00% | – |
Q4 2022 | $573,387 | +124.0% | 253,711 | +90.8% | 0.00% | – |
Q3 2022 | $256,000 | -48.5% | 132,980 | -0.5% | 0.00% | – |
Q2 2022 | $497,000 | -66.2% | 133,591 | -40.7% | 0.00% | – |
Q1 2022 | $1,469,000 | +247.3% | 225,349 | +520.2% | 0.00% | – |
Q4 2021 | $423,000 | -55.4% | 36,337 | +1.6% | 0.00% | – |
Q4 2020 | $949,000 | -82.7% | 35,752 | -85.4% | 0.00% | -100.0% |
Q3 2020 | $5,489,000 | – | 245,034 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |